» Articles » PMID: 28543959

Epidemiology of Urothelial Carcinoma

Overview
Journal Int J Urol
Specialty Urology
Date 2017 May 26
PMID 28543959
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

The epithelium lining is defined as the mucosal surfaces of the renal collecting tubules, calyces and pelvis, as well as the ureter, bladder and urethra. The term "urothelium" is used to refer to these surfaces. Upper tract urothelial carcinoma is a rare subset of urothelial cancers with a poor prognosis. Urinary bladder cancer is the most common malignancy involving the urinary system. Upper tract urothelial carcinoma is more common in men than in women, with a male-to-female ratio of 2:1. The incidence of urinary bladder cancer is also higher in men. Cigarette smoking and occupational exposure are the main upper tract urothelial carcinoma and urinary bladder cancer risk factors, while other factors are more specific to the carcinogenesis of upper tract urothelial carcinoma (i.e. Balkan endemic nephropathy, Chinese herb nephropathy). In Egypt until recent years, urinary bladder cancer was the most frequently diagnosed cancer due to Schistosoma haematobium. Substantial knowledge exists regarding the causes of upper tract urothelial carcinoma and urinary bladder cancer, and epidemiological studies have identified various chemical carcinogens that are believed to be responsible for most cases of urothelial carcinoma. In the era of precision medicine, genetic effects might play a direct role in the initiation and progression of urothelial carcinoma.

Citing Articles

Urine proteomics-based analysis identifies CHI3L1 as an immune marker and potential therapeutic target for bladder cancer.

Wang C, Li K, Huang R, Wan S, Chen S, Liu S BMC Cancer. 2025; 25(1):271.

PMID: 39955518 PMC: 11830209. DOI: 10.1186/s12885-025-13668-1.


Tumor-shrinking effects of enfortumab vedotin between primary urothelial carcinoma and metastatic organs.

Ikarashi D, Kawamura T, Ogasawara K, Arakawa Y, Machida A, Ito A Front Oncol. 2025; 14:1493922.

PMID: 39943993 PMC: 11813790. DOI: 10.3389/fonc.2024.1493922.


Clinical and molecular analysis of JCPyV and BKPyV infection and associated risk of urothelial carcinoma development in the upper tract.

Chao C, Hung C, Lai W, Tung C, Yeh W, Yang K Virol J. 2025; 22(1):32.

PMID: 39923063 PMC: 11806556. DOI: 10.1186/s12985-025-02643-8.


Performance of urine DNA Neuritin 1 methylation test for urothelial carcinoma detection.

Wu Y, Gong Y, Zhou L, Xu A, Li X Mol Biomed. 2025; 6(1):8.

PMID: 39920484 PMC: 11805734. DOI: 10.1186/s43556-025-00245-y.


Single-Cell RNA Sequencing Reveals the Tumor Heterogeneity and Immunosuppressive Microenvironment in Urothelial Carcinoma.

Lyu T, Wu K, Zhou Y, Kong T, Li L, Wang K Cancer Sci. 2024; 116(3):710-723.

PMID: 39726326 PMC: 11875766. DOI: 10.1111/cas.16436.